Rajan P. Kulkarni

Dermatology

3303 S Bond Ave
Portland, OR 97239

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 61 publications

Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis.

Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis.

Journal: Dermatology and therapy

Published: February 02, 2026

Updates on intratumoral therapies in melanoma.

Updates on intratumoral therapies in melanoma.

Journal: Cancer

Published: October 26, 2025

The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors.

The impact of concomitant medications on treatment outcomes in patients with cancer receiving immune checkpoint inhibitors.

Journal: Nature reviews. Cancer

Published: October 17, 2025

Next-gen tools in cancer neuroscience.

Next-gen tools in cancer neuroscience.

Journal: Cell reports

Published: June 01, 2025

MIF as an oncogenic driver of low-heterogeneity melanomas.

MIF as an oncogenic driver of low-heterogeneity melanomas.

Journal: Molecular oncology

Published: March 05, 2025

A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma.

A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanoma.

Journal: Cell reports

Published: January 31, 2025

Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1.

Improving immunotherapy responses by dual inhibition of macrophage migration inhibitory factor and PD-1.

Journal: JCI insight

Published: January 23, 2025

Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy.

Personalization of Cancer Treatment: Exploring the Role of Chronotherapy in Immune Checkpoint Inhibitor Efficacy.

Journal: Cancers

Published: November 04, 2024

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.

Prognostic and therapeutic insights into MIF, DDT, and CD74 in melanoma.

Journal: Oncotarget

Published: July 19, 2024

Bridging single cells to organs: Mesoscale modules as fundamental units of tissue function.

Bridging single cells to organs: Mesoscale modules as fundamental units of tissue function.

Journal: Cell

Published: March 17, 2024

MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.

MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.

Journal: Cancers

Published: March 14, 2024

Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers.

Comparison of Immunotherapy versus Targeted Therapy Effectiveness in BRAF-Mutant Melanoma Patients and Use of cGAS Expression and Aneuploidy as Potential Prognostic Biomarkers.

Journal: Cancers

Published: February 01, 2024

Showing 1-12 of 61

Last Updated: 09/26/2026